1. Home
  2. RNTX vs ZDGE Comparison

RNTX vs ZDGE Comparison

Compare RNTX & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.02

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

Logo Zedge Inc. Class B

ZDGE

Zedge Inc. Class B

HOLD

Current Price

$3.14

Market Cap

39.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNTX
ZDGE
Founded
2001
2008
Country
United States
United States
Employees
10
55
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
39.9M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
RNTX
ZDGE
Price
$1.02
$3.14
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
841.5K
64.6K
Earning Date
05-15-2026
06-11-2026
Dividend Yield
N/A
1.96%
EPS Growth
N/A
73.85
EPS
N/A
N/A
Revenue
N/A
$29,398,000.00
Revenue This Year
N/A
$3.27
Revenue Next Year
N/A
$5.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$2.21
52 Week High
$2.18
$4.70

Technical Indicators

Market Signals
Indicator
RNTX
ZDGE
Relative Strength Index (RSI) 39.26 54.60
Support Level N/A $2.89
Resistance Level $1.33 $3.43
Average True Range (ATR) 0.08 0.19
MACD 0.01 0.03
Stochastic Oscillator 24.94 84.29

Price Performance

Historical Comparison
RNTX
ZDGE

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About ZDGE Zedge Inc. Class B

Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.

Share on Social Networks: